Left Ventricular Ejection Fraction and Intensive Up-Titration of Oral Treatment in Patients Recently Hospitalized for Heart Failure: Insights From the STRONG-HF Trial
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Personal fees - Abbott Vascular; AstraZenca; Boehringer Ingelheim; Vifor Pharma